All Episodes
The Freshfields Podcast — 124 episodes
No Worse Off #26: Finding Your Voice
Well-Caffeinated: Not Just a Speed Bump — Identifying and Managing Conflicts of Interest in Private Funds
No Worse Off #25: From burnout to buy-out: the Bulb Energy story
No Worse Off #24: Minority protection in English LME
Essential Antitrust – The Italian Voice #2: La dura legge del goal
'EUnpacked' #5: The EU ETS Revision – what’s next for Europe’s carbon market?
No Worse Off #23: Restructuring in the Netherlands
Well-Caffeinated: What the Retail Moment Means for Private Capital
Essential Antitrust #51: Inside the new EU Merger Guidelines with Daniele Calisti: policy, economics and practice
Essential Antitrust - The Italian Voice #1: Il posto fisso (obbligato)
Global Shareholder Activism Insights #1: The Rise of the First-Time Activist
Essential Antitrust #50: New safe harbours, sharper teeth - the EU's new merger playbook
No Worse Off #22: Welcome to Hot Topics: charting global restructuring, one jurisdiction at a time
Introducing the AI Drop
Well-Caffeinated: Private Capital at the AI Inflection Point: What to Look for in 2026 and Beyond
No Worse Off #21: Asset-Backed Finance under stress
ESG trends to watch in 2026: Part 2: How AI, climate transition planning, supply chains and environmental rules are evolving
ESG trends to watch in 2026: Part 1: ESG litigation risk in a fragmented regulatory world
Essential Antitrust #49: Clarity in Antitrust: inside the 10 key themes shaping 2026
Essential Antitrust #48: Antitrust meets AI: How regulators approach AI-driven pricing and predictive analytics
Well-Caffeinated: What’s Past is Prologue — Assessing the Changed Legal Landscape from Year 1 of the Second Trump Administration and Looking Ahead at What Year 2 May Bring
No Worse Off #20: 2025 in Review
No Worse Off #19: Restructuring “à la francaise”
Tax Matters: Autumn Budget 2025 – a stealthy smorgasbord?
No Worse Off #18: Innovative Capital Solutions Tools in the Italian Market
Human-Centered Innovation – A conversation with Stephanie Toney, CBO at Diatiro Health
Well-Caffeinated: Private Capital Goes Retail: the Global Push to Democratize Access to Private Capital Investments
No Worse Off #17: Distressed disposals and LMEs – Hunkemöller and Selecta
The Arbitration Act 2025 is now in force. What are the key things you need to know?
No Worse Off #16: Petrofac in the Court of Appeal
Reward(ing) Half Hour - Episode 5 Navigating Employment Claims: Share Plans, Bonuses and Beyond
No Worse Off #15: UK restructuring plan turns five
Eureka: Fresh Takes on Capital Markets with Freshfields Episode #4: Midseason Proxy Review
Eureka: Fresh Takes on Capital Markets from Freshfields Episode #3: What to expect from SEC Enforcement
Tax matters: Trump 2.0 - the intersection of US tax and trade policy
Looking Forward: How AI is Transforming Healthcare and MedTech
Essential Antitrust #47: Chat with EC’s Daniele Calisti: More room for procompetitive efficiencies?
'EUnpacked' Episode #4: The EU’s first Omnibus - simplification or deregulation?
No Worse Off #14: Managing consumer redress liabilities: recent restructuring experience and the motor finance sector
Securing the Digital Future #4: A Conversation with Athina Tsitsou and June Lowry
Eureka: Fresh Takes on Capital Markets with Freshfields Episode #2: IPOs and other Routes to Capital and Liquidity: “The Garden of Forking Paths”
Eureka: Fresh Takes on Capital Markets from Freshfields: Episode #1: Disclosure and Governance During a Trade War
Ethan Klingsberg Explores the Global Secondaries Trend with Ivet Bell
Essential Antitrust #46: UK’s DMCCA consumer protection reforms: Key changes and how to prepare
No Worse Off #13: Spotlight on the Middle East
Well-Caffeinated: Playing the Long Game: A Conversation with Val Jacob
Securing the Digital Future #3: Balancing Act: Regulatory Approaches to Privacy in Content Moderation
No Worse Off #12: Meet Paul, Mark and Nick: our new London private credit and capital solutions trio
Managing Risk in Asia #10: Powering the change in Asia’s energy transition
Securing the Digital Future #2: Navigating the UK’s Approach to Online Safety
MedTech - Innovation & Inclusion: How Nada Hanafi advocates for diversity in MedTech
No Worse Off #11: International sanctions
Essential Antitrust #45: Antitrust agency leadership: stepping onto a new stage
Essential Antitrust #44: Redefining the role of antitrust in 2025: our Ten Key Themes forecast
Securing the Digital Future #1: Insights on online safety in the US
Life Sciences x Technology – A conversation with Derek Underwood
No Worse Off #10: 12 Headlines from 2024
Reward(ing) Half Hour: Episode 4 Applying Malus and Clawback in practice
Essential Antitrust #43: EU welcomes Teresa Ribera as new Competition Commissioner: business impact
Well-Caffeinated: What’s Brewing for the 2025 Funds Regulatory Environment?
No Worse Off #9: Managing Litigation Risk in Restructurings
Tax Matters: Autumn Budget 2024 – Delivering difficult decisions
Essential Antitrust #42: HSR rules changes: how to successfully navigate the new US merger control filing
No Worse Off #8: LMEs in England
Episode #3: EU elections - What you need to know about the von der Leyen II Commission
Out of the shadows: The growing regulatory spotlight on private capital
No Worse Off #7: Women in Restructuring
No Worse Off #6: Liability management
Essential Antitrust #41: Vertical restraints enforcement: trends to watch
Navigating Cybersecurity Risks in the Healthcare Sector
Episode #2: EU elections - A business outlook
No Worse Off #5: Cross-border restructurings
Essential Antitrust #40: America’s impending outbound investment controls: what investors need to know
Managing Risk in Asia #9: Southeast Asia – time to shine?
Reward(ing) Half Hour: Episode 3 Next Stop: CSOP
Reward(ing) Half Hour: Episode 2 Remuneration vs Compensation – the Transatlantic Pay Debate
No Worse Off #4: Richard Tett, 30 years in restructuring
Essential Antitrust #39: UK in-depth merger reviews: new process adopted by the CMA
No Worse Off #3: UK Restructuring Plans – Relevant Alternative, timetabling and jurisdiction
No Worse Off #2: After the battles, a coming of age for the UK restructuring plan?
Reward(ing) Half Hour: Being prepared for the (not so) unexpected: planning for executive exits
Tax Matters: Spring Budget 2024 – The Hunt for Blue October
No Worse Off #1: Overview of current restructuring trends
Essential Antitrust #38: What businesses can expect from China’s revised merger control regime
Impressions from the J.P. Morgan Healthcare Conference – A MedTech Perspective
Essential Antitrust #37: Antitrust in 2024: competition enforcement takes center stage
Legends of Tech #1: Turing with Vint and Whit: Boris Feldman in conversation with Vinton G. Cerf and Whitfield Diffie
Essential Antitrust Asia #9: updates with ABNR on antitrust in Indonesia
Managing Risk in Asia #8: Opportunities for Asian and US investors post-US Executive Order on outbound investments
Tax Matters: Trends in tax disputes – what should businesses be aware of?
Essential Antitrust #36: The UK’s Digital Markets, Competition and Consumers Bill – what you need to know
Essential Antitrust #35: Gender Inclusive Antitrust Toolkit: a new lens for policy and enforcement
Tax Matters: Autumn Statement 2023 – tax cuts in the NIC of time?
How secondaries have become primary to GPs and LPs
From chaos to control: making the case for legal project managers
Essential Antitrust #34: Olivier Guersent on competition enforcement: current trends
Essential Antitrust #33: Antitrust insights in Asia: navigating complex regulations and investment challenges
MedTech Across Borders – Recent Developments in Japan and the US
MedTech x Creating System Change – Reducing clinician burnout, effectively using AI and more
Essential Antitrust #32: New US HSR Rules and Merger Guidelines: key takeaways
Managing risk in Asia #7: Managing licensing and collaboration risks in the life sciences arena in Asia
Essential Antitrust #31: Recent developments in antitrust, data and IP – generative AI and MedTech
Essential Antitrust #30: ASSA ABLOY/Spectrum Brands: a breakthrough for M&A remedies in the US?
Essential Antitrust #29: Microsoft/Activision: parallel reviews in high-innovation digital deals
Global Perspectives on Health Data Offerings and Considerations for Innovators
Essential Antitrust #28: Collusion or collaboration: competition and the fight for net zero
Essential Antitrust #27: Some Key Takeaways from the Enforcers Roundtable at the 2023 ABA Antitrust Spring Meeting
MedTech Diversity and Inclusion – A Conversation with Jhaymee Tynan
Episode #1: The EU’s Corporate Sustainability Due Diligence Directive– a turning point for business
Essential Antitrust Asia #8: Hot topics in China antitrust
Tax Matters: Ready, Steady, Growth – Business tax implications of the UK Spring Budget 2023
Essential Antitrust #26: Foreign subsidy control: EU gears up to review deals and business conduct
Essential Antitrust #25: Antitrust in 2023: 10 key themes - growing unpredictability and brand new enforcement tools
MedTech - A Conversation with Stacy Hostetler
Essential Antitrust #24: Cartel enforcement is back: dawn raids in Europe and new targets in the US
MedTech - A Conversation with Gloria Seibert
Tax Matters podcast: How will the UK Autumn Statement 2022 affect your business?
Essential Antitrust #23: Merger challenges in US courts: deciphering US antitrust agencies’ recent string of defeats
Great (stakeholder) expectations: Episode 4 - Activists all around
Great (stakeholder) expectations: Episode 3 - A bastion of support for social issues
Great (stakeholder) expectations: Episode 2 - Unpacking the status of climate disclosures
State of play on Pillar Two
Great (stakeholder) expectations: Episode 1 - A turning point for ESG
Essential Antitrust Asia #7: Key antitrust issues in Japan